2023
DOI: 10.3390/vaccines11010125
|View full text |Cite
|
Sign up to set email alerts
|

Intensive Care during the COVID-19 Pandemic

Abstract: The novel coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a sudden sharp rise in hospitalizations for pneumonia with multiorgan disease [...]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 53 publications
0
1
0
1
Order By: Relevance
“…To date, more than 200 COVID-19 vaccine candidates are in various stages of development, and more than 50 of these candidates have started clinical trials. These candidates may use inactivated or live attenuated viruses, nucleic acids (DNA or RNA), viral vectors, recombinant proteins or virus particles [ 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 ]. WHO is committed to keeping the momentum for boosting access to COVID-19 vaccinations going and will continue to assist countries in expediting vaccine delivery in order to save lives and prevent people from becoming seriously ill.…”
Section: Introductionmentioning
confidence: 99%
“…To date, more than 200 COVID-19 vaccine candidates are in various stages of development, and more than 50 of these candidates have started clinical trials. These candidates may use inactivated or live attenuated viruses, nucleic acids (DNA or RNA), viral vectors, recombinant proteins or virus particles [ 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 ]. WHO is committed to keeping the momentum for boosting access to COVID-19 vaccinations going and will continue to assist countries in expediting vaccine delivery in order to save lives and prevent people from becoming seriously ill.…”
Section: Introductionmentioning
confidence: 99%
“…3, nota-se que 65% dos casos da covid-19 Em comparação com outros estudos, observa-se que as queixas de reações adversas são comparáveis e, na maioria dos casos, não representam riscos à saúde dos pacientes. Além disso, as vantagens da vacinação apresentam bene昀cios signi昀椀ca琀椀vos mais relevantes do que as desvantagens, exceto em situações especí昀椀cas e raras de reações adversas ou quando a vacinação não é indicada14 . precisão dessas informações pode ser afetada pela lembrança subje琀椀va dos par琀椀cipantes, o que pode levar a um relato parcial e subiden琀椀昀椀cação dos medicamentos usados, ou seja, os que foram lembrados.…”
unclassified